Release Date: 29/05/12 09:16 Summary: AGL PRO RATA RENOUNCEABLE ENTITLEMENT OFFER Price Sensitive: Yes Download Document 114.38KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status